How did Optimizerx's revenue and expenses trend in Q4 2024?

**OptimizeRx Corporation's revenue and expenses in Q4 2024 reflect a company that continues to navigate challenges while demonstrating resilience in its core business operations.** 1. **Revenue Trend**: - OptimizeRx reported a year-over-year increase in revenue for Q4 2024, with sales reaching $32.32 million, up from $28.37 million in the same quarter the previous year. - This growth was attributed to a 30% increase in revenue, reaching $21.3 million in Q3 2024, compared to $16.3 million in the same quarter the previous year. 2. **Expense Analysis**: - Despite the revenue growth, OptimizeRx reported a net loss of $9.1 million for Q3 2024, primarily due to a $7.5 million goodwill impairment charge. - The company's gross profit increased by 37% year-over-year to $13.4 million, with a gross margin of 63%. - Operating expenses were higher at $22,009,000 compared to $13,353,000 in the same quarter the previous year, mainly due to goodwill impairment and increased general and administrative expenses following the acquisition. 3. **Strategic Shifts and Challenges**: - OptimizeRx has been transitioning from managed services to a self-service model in its DTC business, which has not yet fully offset the decline in managed services revenue. - The integration of acquired businesses, such as MediHealth, has posed challenges in capturing customer wallet share during the sales cycle. - The company's focus on cost savings and operational efficiencies post-integration has been a positive point, contributing to its bottom line and cash flow. 4. **Financial Position**: - As of September 30, 2024, OptimizeRx had cash, cash equivalents, and short-term investments totaling $16.1 million. - The company's stockholders’ equity stood at $114,465,000, with total liabilities and equity amounting to $165,199,000. In conclusion, while OptimizeRx has seen revenue growth and cost improvements in certain areas, the net effect for Q4 2024 is a net loss due to significant expenses related to acquisitions and operational transitions. The company's strategic shifts and cost-saving measures are positive signs, but they are still working through the challenges of integrating new businesses and transitioning its DTC model.